GO:0006139 | nucleobase-containing compound metabolic process | 27.94% (19/68) | 3.09 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 27.94% (19/68) | 2.97 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 27.94% (19/68) | 2.93 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 27.94% (19/68) | 2.9 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 23.53% (16/68) | 3.19 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 27.94% (19/68) | 2.65 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 19.12% (13/68) | 3.43 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 13.24% (9/68) | 3.97 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 47.06% (32/68) | 1.46 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 16.18% (11/68) | 3.13 | 0.0 | 2e-06 |
GO:0006807 | nitrogen compound metabolic process | 38.24% (26/68) | 1.6 | 0.0 | 3e-06 |
GO:0009451 | RNA modification | 8.82% (6/68) | 4.57 | 0.0 | 7e-06 |
GO:0005488 | binding | 55.88% (38/68) | 1.04 | 1e-06 | 1.5e-05 |
GO:0044238 | primary metabolic process | 39.71% (27/68) | 1.41 | 1e-06 | 1.5e-05 |
GO:0044237 | cellular metabolic process | 33.82% (23/68) | 1.61 | 1e-06 | 1.6e-05 |
GO:0003676 | nucleic acid binding | 25.0% (17/68) | 1.94 | 1e-06 | 2.8e-05 |
GO:0009987 | cellular process | 41.18% (28/68) | 1.29 | 2e-06 | 4e-05 |
GO:0071704 | organic substance metabolic process | 39.71% (27/68) | 1.31 | 2e-06 | 5.1e-05 |
GO:0003674 | molecular_function | 70.59% (48/68) | 0.72 | 3e-06 | 6.2e-05 |
GO:0097159 | organic cyclic compound binding | 38.24% (26/68) | 1.28 | 6e-06 | 0.000112 |
GO:0008150 | biological_process | 54.41% (37/68) | 0.91 | 9e-06 | 0.000161 |
GO:0043170 | macromolecule metabolic process | 30.88% (21/68) | 1.45 | 1.2e-05 | 0.000202 |
GO:0006397 | mRNA processing | 5.88% (4/68) | 4.29 | 5.5e-05 | 0.000896 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 4.41% (3/68) | 5.31 | 6.2e-05 | 0.000964 |
GO:0034470 | ncRNA processing | 5.88% (4/68) | 4.19 | 7.2e-05 | 0.001075 |
GO:0016071 | mRNA metabolic process | 5.88% (4/68) | 4.01 | 0.000116 | 0.001553 |
GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 2.94% (2/68) | 6.96 | 0.000114 | 0.001587 |
GO:0003824 | catalytic activity | 42.65% (29/68) | 0.95 | 0.000112 | 0.001616 |
GO:0016874 | ligase activity | 5.88% (4/68) | 3.88 | 0.000166 | 0.002143 |
GO:0008033 | tRNA processing | 4.41% (3/68) | 4.77 | 0.000186 | 0.002327 |
GO:0140097 | catalytic activity, acting on DNA | 5.88% (4/68) | 3.63 | 0.000321 | 0.003881 |
GO:0034660 | ncRNA metabolic process | 5.88% (4/68) | 3.6 | 0.000346 | 0.004051 |
GO:0009982 | pseudouridine synthase activity | 2.94% (2/68) | 5.82 | 0.000579 | 0.006581 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 8.82% (6/68) | 2.52 | 0.000637 | 0.006821 |
GO:0006974 | DNA damage response | 5.88% (4/68) | 3.37 | 0.000625 | 0.006896 |
GO:0001522 | pseudouridine synthesis | 2.94% (2/68) | 5.63 | 0.00075 | 0.00781 |
GO:0033554 | cellular response to stress | 5.88% (4/68) | 3.19 | 0.000982 | 0.009952 |
GO:0051716 | cellular response to stimulus | 5.88% (4/68) | 3.14 | 0.001122 | 0.011077 |
GO:0035600 | tRNA methylthiolation | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0004638 | phosphoribosylaminoimidazole carboxylase activity | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0106388 | 18S rRNA aminocarboxypropyltransferase activity | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0032963 | collagen metabolic process | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0005848 | mRNA cleavage stimulating factor complex | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0004639 | phosphoribosylaminoimidazolesuccinocarboxamide synthase activity | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0004573 | Glc3Man9GlcNAc2 oligosaccharide glucosidase activity | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0031348 | negative regulation of defense response | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0035598 | N6-threonylcarbomyladenosine methylthiotransferase activity | 1.47% (1/68) | 9.28 | 0.001612 | 0.012089 |
GO:0006399 | tRNA metabolic process | 4.41% (3/68) | 3.83 | 0.001265 | 0.012166 |
GO:1902494 | catalytic complex | 5.88% (4/68) | 2.94 | 0.001868 | 0.013737 |
GO:0009064 | glutamine family amino acid metabolic process | 2.94% (2/68) | 5.15 | 0.001472 | 0.013796 |
GO:0006400 | tRNA modification | 2.94% (2/68) | 4.88 | 0.002114 | 0.015245 |
GO:1901605 | alpha-amino acid metabolic process | 4.41% (3/68) | 3.52 | 0.00232 | 0.016412 |
GO:0015926 | glucosidase activity | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0006884 | cell volume homeostasis | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0008361 | regulation of cell size | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0008296 | 3'-5'-DNA exonuclease activity | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0034709 | methylosome | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0050497 | alkylthioltransferase activity | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0034715 | pICln-Sm protein complex | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0035596 | methylthiotransferase activity | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0003942 | N-acetyl-gamma-glutamyl-phosphate reductase activity | 1.47% (1/68) | 8.28 | 0.003221 | 0.018873 |
GO:0032991 | protein-containing complex | 10.29% (7/68) | 1.89 | 0.002786 | 0.019348 |
GO:0005634 | nucleus | 5.88% (4/68) | 2.68 | 0.003544 | 0.020445 |
GO:0016782 | transferase activity, transferring sulphur-containing groups | 2.94% (2/68) | 4.6 | 0.003101 | 0.021146 |
GO:0016866 | intramolecular transferase activity | 2.94% (2/68) | 4.47 | 0.003727 | 0.021174 |
GO:0043167 | ion binding | 25.0% (17/68) | 0.99 | 0.003912 | 0.021893 |
GO:0043412 | macromolecule modification | 14.71% (10/68) | 1.41 | 0.004098 | 0.022598 |
GO:0003906 | DNA-(apurinic or apyrimidinic site) endonuclease activity | 1.47% (1/68) | 7.69 | 0.004828 | 0.024465 |
GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity | 1.47% (1/68) | 7.69 | 0.004828 | 0.024465 |
GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity | 1.47% (1/68) | 7.69 | 0.004828 | 0.024465 |
GO:0000702 | oxidized base lesion DNA N-glycosylase activity | 1.47% (1/68) | 7.69 | 0.004828 | 0.024465 |
GO:0006529 | asparagine biosynthetic process | 1.47% (1/68) | 7.69 | 0.004828 | 0.024465 |
GO:0006528 | asparagine metabolic process | 1.47% (1/68) | 7.69 | 0.004828 | 0.024465 |
GO:0042274 | ribosomal small subunit biogenesis | 1.47% (1/68) | 7.28 | 0.006432 | 0.030922 |
GO:0033588 | elongator holoenzyme complex | 1.47% (1/68) | 7.28 | 0.006432 | 0.030922 |
GO:0030870 | Mre11 complex | 1.47% (1/68) | 7.28 | 0.006432 | 0.030922 |
GO:0006281 | DNA repair | 4.41% (3/68) | 3.0 | 0.006325 | 0.031623 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.94% (2/68) | 4.01 | 0.006928 | 0.032476 |
GO:0005515 | protein binding | 20.59% (14/68) | 1.04 | 0.006915 | 0.032822 |
GO:0140513 | nuclear protein-containing complex | 4.41% (3/68) | 2.94 | 0.007101 | 0.032873 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.94% (2/68) | 3.94 | 0.00764 | 0.034939 |
GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 1.47% (1/68) | 6.96 | 0.008033 | 0.035029 |
GO:0000178 | exosome (RNase complex) | 1.47% (1/68) | 6.96 | 0.008033 | 0.035029 |
GO:0004529 | DNA exonuclease activity | 1.47% (1/68) | 6.96 | 0.008033 | 0.035029 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.47% (1/68) | 6.96 | 0.008033 | 0.035029 |
GO:1901566 | organonitrogen compound biosynthetic process | 7.35% (5/68) | 2.0 | 0.008353 | 0.036004 |
GO:0004520 | DNA endonuclease activity | 1.47% (1/68) | 6.69 | 0.009632 | 0.038023 |
GO:0006541 | glutamine metabolic process | 1.47% (1/68) | 6.69 | 0.009632 | 0.038023 |
GO:0035145 | exon-exon junction complex | 1.47% (1/68) | 6.69 | 0.009632 | 0.038023 |
GO:1905354 | exoribonuclease complex | 1.47% (1/68) | 6.69 | 0.009632 | 0.038023 |
GO:0005849 | mRNA cleavage factor complex | 1.47% (1/68) | 6.69 | 0.009632 | 0.038023 |
GO:0008168 | methyltransferase activity | 4.41% (3/68) | 2.77 | 0.009854 | 0.038097 |
GO:0032259 | methylation | 2.94% (2/68) | 3.75 | 0.009759 | 0.038122 |
GO:0006164 | purine nucleotide biosynthetic process | 2.94% (2/68) | 3.72 | 0.010169 | 0.038521 |
GO:1901363 | heterocyclic compound binding | 17.65% (12/68) | 1.08 | 0.010117 | 0.038714 |
GO:0008380 | RNA splicing | 2.94% (2/68) | 3.71 | 0.010377 | 0.038915 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.41% (3/68) | 2.8 | 0.00928 | 0.039544 |
GO:0036094 | small molecule binding | 17.65% (12/68) | 1.07 | 0.010668 | 0.03961 |
GO:0043227 | membrane-bounded organelle | 5.88% (4/68) | 2.27 | 0.009599 | 0.039994 |
GO:0043231 | intracellular membrane-bounded organelle | 5.88% (4/68) | 2.27 | 0.009599 | 0.039994 |
GO:0016741 | transferase activity, transferring one-carbon groups | 4.41% (3/68) | 2.69 | 0.011487 | 0.040638 |
GO:0140657 | ATP-dependent activity | 5.88% (4/68) | 2.2 | 0.011272 | 0.040645 |
GO:0044281 | small molecule metabolic process | 7.35% (5/68) | 1.89 | 0.011381 | 0.040647 |
GO:0000373 | Group II intron splicing | 1.47% (1/68) | 6.47 | 0.011229 | 0.040882 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.47% (1/68) | 6.47 | 0.011229 | 0.040882 |
GO:0002098 | tRNA wobble uridine modification | 1.47% (1/68) | 6.28 | 0.012823 | 0.043321 |
GO:0018202 | peptidyl-histidine modification | 1.47% (1/68) | 6.28 | 0.012823 | 0.043321 |
GO:0017183 | protein histidyl modification to diphthamide | 1.47% (1/68) | 6.28 | 0.012823 | 0.043321 |
GO:0006520 | amino acid metabolic process | 4.41% (3/68) | 2.64 | 0.012582 | 0.044096 |
GO:0072522 | purine-containing compound biosynthetic process | 2.94% (2/68) | 3.55 | 0.012788 | 0.044403 |
GO:0004536 | DNA nuclease activity | 1.47% (1/68) | 6.11 | 0.014414 | 0.047835 |
GO:0002097 | tRNA wobble base modification | 1.47% (1/68) | 6.11 | 0.014414 | 0.047835 |
GO:0048585 | negative regulation of response to stimulus | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0090066 | regulation of anatomical structure size | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0000209 | protein polyubiquitination | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0016553 | base conversion or substitution editing | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0005829 | cytosol | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0032535 | regulation of cellular component size | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0016783 | sulfurtransferase activity | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0042026 | protein refolding | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.47% (1/68) | 5.82 | 0.01759 | 0.04886 |
GO:1901607 | alpha-amino acid biosynthetic process | 2.94% (2/68) | 3.43 | 0.014924 | 0.049092 |
GO:0008652 | amino acid biosynthetic process | 2.94% (2/68) | 3.29 | 0.017993 | 0.049612 |